MP

Mark P. Stevenson

Europe, United Kingdom

Description

Life Sciences Investor & Board member | Former EVP & COO Thermo Fisher Scientific

Investor Profile

Mark P. Stevenson has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Genetics, Health Care.

Stage Focus

  • Seed (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mark P. Stevenson frequently co-invest with?

OMERS Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
MV
North America, California, United States, San Francisco
Co-Investments: 1
DCVC
North America, California, United States, San Francisco
Co-Investments: 1
Firstminute Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does Mark P. Stevenson often collaborate with?

PS
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Mark P. Stevenson?

Relation Therapeutics

London, England, United Kingdom

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

BiotechnologyGeneticsHealth CareMedical
SeedJun 9, 2022
Amount Raised: $25,000,000